腫瘍学研究におけるデータ管理の課題を克服する:NHS,産業,テクノロジースタートアップ,学術的協力からの教訓
Alicia-Marie Conway1, Matthew Concannon2, Steven Brown2
1Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK; Nucleic Acid Biomarker Team, Cancer Research UK, National Biomarker Centre, The University of Manchester, Manchester, UK.
European journal of cancer (Oxford, England : 1990)
|August 21, 2025
まとめ
イギリスのプロジェクトは,腫瘍学の研究のための大規模なゲノムとマルチモダルのデータを安全に保存し共有するためにデータレイクを使用しました. このアプローチは 協働と堅実なガバナンスで 将来の精密腫瘍学イニシアチブに 模範となるものです
科学分野:
- 腫瘍学
- ゲノミクス
- データサイエンス
背景:
- 腫瘍学の研究を進めるには,大規模なゲノムとマルチモダルのデータを統合する必要があります.
- データの保存,共有,ガバナンスに関する課題は,このデータの有効な利用を妨げています.
- 腫瘍学研究におけるマルチモダルのデータ利用を最適化することを目的とした,複数のサイトを網羅する英国プロジェクトです.
研究 の 目的:
- 経験を共有し,腫瘍学研究における多式データの使用を可能にし,最適化するための勧告を提供すること.
- 大規模なゲノムデータセットのデータ保存,共有,ガバナンスに関する課題に取り組む.
- 複数の利害関係者の協力による強力なデータ管理戦略を開発する.
主な方法:
- NHS トラスト,産業,スタートアップ,学術的なパートナーを含む共同アプローチが採用されました.
- データレイクアーキテクチャは,多様なデータセットのための集中され,安全なリポジトリとして選択されました.
- データストレージ,アクセス制御,所有権,情報ガバナンスなどの重要な要因は,ソリューションの選択と実装に影響を与えました.
主要な成果:
- このデータレイクは,大規模なゲノムと臨床データの安全でコンプライアントで統合されたストレージを可能にしました.
- 早期の利害関係者の関与と明確なデータガバナンスフレームワークは,成功するために不可欠でした.
- 技術的ソリューションとガバナンス,セキュリティ,アクセシビリティの要件を様々なパートナーの間で調和させることが不可欠でした.
結論:
- 効果的な多式データ管理には 積極的な計画,多方関係者の関与,そして強力なガバナンスが必要です.
- データレイクモデルは,安全で協力的なゲノムデータ研究のためのスケーラブルでコンプライアントな方法を提供します.
- このアプローチは,将来の精密腫瘍学イニシアチブのテンプレートとして機能します.
関連する概念動画
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:21Cancer Survival Analysis
453
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
453
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
02:43Mouse Models of Cancer Study
5.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.7K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174